Virus containment measures imposed by the Chinese government have resulted in shutdowns or partial closures at manufacturing plants in Wuhan, the province in which the new coronavirus emerged, as well as other nearby areas.
For the drug industry, sustained reductions in Chinese production could quickly become a problem. The country accounts for a good deal of the active pharmaceutical ingredients contained in many common drugs, as well as the starting chemicals used to produced those ingredients elsewhere.